Press releases

CORPORATE STATEMENT: Biocartis Joins COVID-19 Testing Industry Consortium of Nineteen Healthcare Community Organizations

Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay

Results of the Extraordinary Shareholders’ Meeting held on 25 September 2020

Large Prospective Lung Cancer Study To Be Presented at ESMO Congress Shows Idylla™ Reduces EGFR Mutation Testing Turnaround Time by More than a Week

Invitation to the Extraordinary Shareholders’ Meeting

Biocartis announces H1 2020 results

Results of the Extraordinary Shareholders’ Meeting held on 2 September 2020

Biocartis Expands Collaboration with LifeArc

Biocartis announces 2020 half-year results on 3 September 2020

Invitation to the Extraordinary Shareholders’ Meeting